Paper Details 
Original Abstract of the Article :
We have used a combination of a beta-blocker and verapamil to treat 42 consecutive patients with angina resistant to either agent alone. Patients with heart failure, heart block or uncontrolled hypertension were excluded. The mean duration of follow-up was 6.5 months. Thirty-six patients (81%) repor...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1136/pgmj.61.713.229

データ提供:米国国立医学図書館(NLM)

A Novel Approach to Treating Resistant Angina

Angina, a type of chest pain caused by reduced blood flow to the heart, can be a frustrating condition for patients. This study delves into the realm of cardiovascular medicine, exploring the effectiveness of a combined approach to treating angina that has resisted treatment with single medications. The authors investigated the use of a beta-blocker and verapamil together in patients whose angina had not responded to either medication alone. Their findings suggest that this combination therapy may be a viable option for a relatively broad range of patients struggling with difficult angina.

Unlocking the Potential of Combination Therapy

The study reports that 81% of the patients experienced improvement in their angina symptoms, highlighting the potential benefits of combining these two medications. However, it's crucial to acknowledge that this combination therapy may require careful dosage adjustments and close monitoring to minimize potential side effects.

A Balanced Approach to Angina Treatment

This research points to the value of carefully considering combination therapies for patients with resistant conditions. The authors emphasize the importance of a personalized approach to treatment, taking into account individual patient needs and potential side effects.

Dr.Camel's Conclusion

The search for effective treatments for resistant angina is an ongoing journey, and this study offers a promising avenue for exploration. While combination therapy can be a powerful tool, it is crucial to proceed with caution and personalized care to ensure the best possible outcomes for each patient.

Date :
  1. Date Completed 1985-05-09
  2. Date Revised 2019-05-01
Further Info :

Pubmed ID

2858847

DOI: Digital Object Identifier

10.1136/pgmj.61.713.229

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.